Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model

Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model

Epstein–Barr virus (EBV) is etiologically associated with a number of malignant and non-malignant conditions. Thus, a prophylactic vaccine against this virus could help to reduce the burden of many EBV-associated diseases. Previously, we reported that an EBV virus-like particle (VLP) vaccine was hig...

Full description

Bibliographic Details
Main Authors: Narendran Reguraman, Asma Hassani, Pretty S. Philip, Dagmar Pich, Wolfgang Hammerschmidt, Gulfaraz Khan
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Vaccines
Subjects:
EBV
vaccine
VLP
rabbits
booster dose
immune response
Online Access:https://www.mdpi.com/2076-393X/11/3/540

Similar Items

Similar Items